Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises

Author： Ahmed Tarek AN   Karalis Ioannis   Jukema J Wouter  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.16, Iss.2, 2011-06, pp. : 203-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease

By Girard S.E.   Temesgen Z.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 765-772

Informa Healthcare

Access to resources Recommend Favorite

Secondary Prevention of Coronary Artery Disease with Antimicrobials: Current Status and Future Directions

By Muhlestein J.B.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 2, 2002-02 ,pp. : 107-118

Adis International

Access to resources Recommend Favorite

Enoxaparin: A Review of its Clinical Potential in the Management of Coronary Artery Disease

By Noble S.   Spencer C.M.  

Drugs, Vol. 56, Iss. 2, 1998-08 ,pp. : 259-272

Adis International

Access to resources Recommend Favorite

Matrix Metalloproteinases in Coronary Artery Disease:Clinical and Therapeutic Implications and Pathological Significance

By  

Current Medicinal Chemistry, Vol. 12, Iss. 8, 2005-04 ,pp. : 917-925

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of Ubiquitin in Peripheral Inflammatory Cells from Patients with Coronary Artery Disease

By Chen S-M   Zhang H-X   Li Y-G   Wang D-M   Zhang G-H   Tan C-J  

The Journal of International Medical Research, Vol. 36, Iss. 6, 2008-11 ,pp. : 1227-1234

Field House Publishing

Access to resources Recommend Favorite